Literature DB >> 11536236

Epidemiological characteristics, risk factors, and clinical manifestations of acute non-A-E hepatitis.

C M Chu1, D Y Lin, C T Yeh, I S Sheen, Y F Liaw.   

Abstract

A substantial proportion of acute non-A, non-B hepatitis was of unknown etiology and was termed non-A-E hepatitis. Analysis of the clinical features is needed while attempting to identify the causative agent(s). In this study, the clinical and biochemical features of 53 patients who were admitted to hospital with acute non-A-E hepatitis were compared with a cohort of patients with acute hepatitis C (n = 70) and E (n = 5). In acute non-A-E hepatitis, the sex ratio was 34:19, and ages ranged from 21 to 76 years (median 49). Biochemical tests [median (range)] revealed albumin 3.6 (2.2-4.4) g/dl, AST 714 (193-2311) U/l, ALT 896 (310-3,000) U/l, bilirubin 11.2 (0.9-36.3) mg/dl, and prothrombin time > 1.1 (0-11.5) seconds. No patients reported parenteral exposures or household contact. Forty-five percent had severe hepatitis (i.e., albumin < 3 g/dl, bilirubin > 15 mg/dl or prothrombin time > 3 sec), including 3% with fulminant hepatitis. Chronic evolution was noted in 7%. These features were similar to those of hepatitis C or E, except for a significantly high frequency of parenteral exposures (20%), household contact (16%), and chronicity (70%) in hepatitis C. In conclusion, there is no obvious parenteral risk factor identified in acute non-A-E hepatitis. Clinical severity is similar to that of hepatitis C at least in hospitalized patients, but the rate of chronic evolution is much lower. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11536236     DOI: 10.1002/jmv.2033

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Human picobirnaviruses identified by molecular screening of diarrhea samples.

Authors:  Marije van Leeuwen; Marisol M W Williams; Penelope Koraka; James H Simon; Saskia L Smits; Albert D M E Osterhaus
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

2.  Quantitative assessment of serum NV-F virus DNA concentrations in samples from patients coinfected with hepatitis B or C virus.

Authors:  Chao-Wei Hsu; Ju-Chien Cheng; Chau-Ting Yeh
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

3.  Exploring the potential of next-generation sequencing in detection of respiratory viruses.

Authors:  Slinporn Prachayangprecha; Claudia M E Schapendonk; Marion P Koopmans; Albert D M E Osterhaus; Anita C Schürch; Suzan D Pas; Annemiek A van der Eijk; Yong Poovorawan; Bart L Haagmans; Saskia L Smits
Journal:  J Clin Microbiol       Date:  2014-08-06       Impact factor: 5.948

4.  Rapid identification of known and new RNA viruses from animal tissues.

Authors:  Joseph G Victoria; Amit Kapoor; Kent Dupuis; David P Schnurr; Eric L Delwart
Journal:  PLoS Pathog       Date:  2008-09-26       Impact factor: 6.823

5.  Identification of sapovirus GV.2, astrovirus VA3 and novel anelloviruses in serum from patients with acute hepatitis of unknown aetiology.

Authors:  Eloy Gonzales-Gustavson; N Timoneda; X Fernandez-Cassi; A Caballero; J F Abril; M Buti; F Rodriguez-Frias; R Girones
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.